Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cross-cultural adaptation, validity and reliability of the Turkish version of the Cognitive Functioning Self-Assessment Scale (CFSS).

Applied neuropsychology. Adult·2025

Same author

A multi-method quasi-experimental study to assess compassion satisfaction/fatigue in nurses, midwives and allied health professionals receiving a narrative medicine intervention.

Journal of advanced nursing·2023

Same author

Psychosocial Impact of Virtual Cancer Care through Technology: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Cancers·2023

Same author

Psychometric properties of the Cognitive Functioning Self-Assessment Scale in community-dwelling adults: A cross-sectional online survey.

Frontiers in psychology·2023

Same author

A Textual Analysis for Understanding the Relations and the Identity Construction in Adolescent Oncology Patients: Retrospective Personal Views in Order to Educate Health Professionals.

Behavioral sciences (Basel, Switzerland)·2022

Same author

Intensity and Prevalence of Psychological Distress in Cancer Inpatients: Cross-Sectional Study Using New Case-Finding Criteria for the Hospital Anxiety and Depression Scale.

Frontiers in psychology·2022

Search research articles

Related Experiment Videos

[Assessing depression in oncology: relevance, issues, modalities].

Maria Antonietta Annunziata, Barbara Muzzatti

Recenti Progressi in Medicina

|November 29, 2011

Summary

Depressive symptoms in cancer patients significantly reduce quality of life and treatment adherence. Addressing these mental health concerns is crucial for improving patient outcomes and survival rates.

Area of Science:

Oncology
Psychiatry
Quality of Life Research

Background:

Depressive symptoms are prevalent in oncological patients, negatively impacting their overall well-being.
These symptoms can lead to decreased therapeutic adherence and poorer treatment outcomes.
The influence of depression on prognosis and survival in cancer patients is a significant clinical concern.

Discussion:

This contribution examines the critical relevance of recognizing and managing depressive symptoms in cancer care.
It addresses the challenges and issues associated with the accurate assessment of depression in this population.
The discussion includes various modalities for registering and documenting depressive states in oncological patients.

Key Insights:

Depression significantly compromises the quality of life for cancer patients.

Related Experiment Videos

Early identification and intervention for depressive symptoms are vital for enhancing therapeutic adherence.

Managing depression is essential for potentially improving prognosis and survival in oncology.

Outlook:

Further research is needed to refine assessment tools for depressive symptoms in diverse oncological populations.
Integrating mental health support into routine cancer care pathways is recommended.
Developing standardized protocols for the registration of depressive symptoms can improve data consistency and clinical decision-making.